The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Chimerix Inc’s stock clocked out at $4.96, down -1.59% from its previous closing price of $5.04. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 2.03 million shares were traded.
Ratios:
To gain a deeper understanding of CMRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 23, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $7.
On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.Maxim Group initiated its Buy rating on April 29, 2021, with a $20 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 13 ’25 when Melemed Allen S. sold 3,065 shares for $4.50 per share. The transaction valued at 13,799 led to the insider holds 152,875 shares of the business.
Andriole Michael T. sold 7,370 shares of CMRX for $33,282 on Feb 13 ’25. The PRESIDENT AND CEO now owns 609,603 shares after completing the transaction at $4.52 per share. On Feb 13 ’25, another insider, Alrutz Michael Albert, who serves as the SVP AND GENERAL COUNSEL of the company, sold 1,600 shares for $4.52 each. As a result, the insider received 7,226 and left with 213,596 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2788.03 while its Price-to-Book (P/B) ratio in mrq is 3.29.
Stock Price History:
Over the past 52 weeks, CMRX has reached a high of $5.53, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is 24.92%, while the 200-Day Moving Average is calculated to be 186.53%.
Shares Statistics:
A total of 89.94M shares are outstanding, with a floating share count of 76.06M. Insiders hold about 15.43% of the company’s shares, while institutions hold 46.48% stake in the company.
